Archive · 17 Jun 2025
Medtronic to Invest $50 Million in Pune Diabetes Center
Medtronic, a medical technology company, is investing $50 million in a new office in Pune, India.
This office will focus on diabetes care and aims to create new products and improve existing services.
They plan to hire many people to assist customers, work on technology, and manage finances.
The diabetes part of Medtronic will become its own independent company, called MiniMed.
This new center should make it easier for people with diabetes to get the support they need.
Medtronic is investing $50 million in a Global Capability Centre (GCC) in Pune, India.
The GCC will focus on diabetes operations and drive innovation and operational excellence.
Over 300 service and software jobs will be created in the first year, with plans to double that.
The center will support customer care, digital tech services, and patient financial services.
Medtronic plans to separate the diabetes business into an independent company called MiniMed.
- Who
- Medtronic, a medical technology company.
- What
- Medtronic is investing in a Global Capability Centre (GCC) for its diabetes operations.
- When
- Over the next five years.
- Where
- Pune, India.
- Why
- To drive innovation, operational excellence, and support people with diabetes.
- Company
- Medtronic
- Investment Amount
- $50 million
- Investment Period
- 5 years
- Location
- Pune, India
- Focus
- Diabetes operations
- Initial Jobs
- 300+
- Future Company Name
- MiniMed